Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Glioblastoma × Chemoradiotherapy × Clear all

Phase

Status

Recruiting 2 Completed 2 Unknown 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Squamous Cell Carcinoma of Head and Neck 2 Rectal Neoplasms 2 Head and Neck Neoplasms 2 Tobacco Use Disorder 1 Smoking Cessation 1 Smoking 1 Sinonasal undifferentiated carcinoma 1 Radiation Injuries 1 Paranasal Sinus Neoplasms 1 Oropharyngeal Neoplasms 1 NSCLC 1 Lung Neoplasms 1 Infiltrating Bladder Urothelial Carcinoma 1 Glioblastoma 1 Gallbladder Neoplasms 1 Esophageal Neoplasms 1 Cardiovascular Diseases 1 Cardiotoxicity 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Temozolomide 45 Radiotherapy 20 Radiation 13 Nivolumab 9 Magnetic Resonance Spectroscopy 9 pembrolizumab 8 Specimen Handling 7 Bevacizumab 7 poly ICLC 4 atezolizumab 4 Lomustine 4 olaparib 3 Surgical Procedures, Operative 3 Photons 3 Ipilimumab 3 Immunoglobulin G 3 Disulfides 3 Cyclophosphamide 3 veliparib 2 trametinib 2 sargramostim 2 rocakinogene sifuplasmid 2 pamiparib 2 niraparib 2 dabrafenib 2 azeliragon 2 Transurethral Resection of Bladder 2 Surveys and Questionnaires 2 Standard of Care 2 Receptors, Interleukin-8B 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02685605 2025-10-14

INTRAGO-II

Universitätsmedizin Mannheim

Phase 3 Active not recruiting

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡